Kailos Genetics, Huntsman Cancer Institute Awarded $2.4M NIH Grant to Develop ctDNA Test | GenomeWeb

NEW YORK (GenomeWeb) – Kailos Genetics announced today that it has received a $2.4 million grant from the National Institutes of Health in collaboration with the University of Utah's Huntsman Cancer Institute (HCI) to develop a clinical-grade test for circulating tumor DNA (ctDNA).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.